This Cardiovascular Catheters market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.
The cardiovascular catheters market size has grown strongly in recent years. It will grow from $20.05 billion in 2024 to $21.87 billion in 2025 at a compound annual growth rate (CAGR) of 9%. The growth in the historic period can be attributed to increase funding for research and development, growth in use of catheters in EP procedures, expansion of cardiac catheterization labs in hospitals, rise in interventional cardiology procedures, and growth in prevalence of diabetes.
The cardiovascular catheters market size is expected to see strong growth in the next few years. It will grow to $30.61 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to focus on reducing healthcare costs, adoption of hybrid operating rooms, rise in investment by both public and private entities in cardiovascular research, increasing use of drug-eluting catheters, and development and adoption of biodegradable catheter materials. Major trends in the forecast period include integration of AI in catheter-based procedures, advanced imaging technologies, development of miniaturized catheters, adoption of robotic-assisted catheter procedures, and development of wireless, battery-free catheters.
The rising prevalence of vascular heart diseases is expected to drive the growth of the cardiovascular catheter market in the future. Vascular heart diseases include various conditions affecting the blood vessels that supply the heart or within the heart itself. Contributing factors such as poor lifestyle habits, aging populations, and increasing rates of diabetes and hypertension are leading to more cases of these diseases. Cardiovascular catheters are essential for patients with vascular heart conditions as they enable minimally invasive procedures to diagnose, treat, and manage issues such as blocked arteries and irregular heart rhythms, resulting in quicker recovery and better outcomes. For instance, in January 2024, the American Heart Association, a US-based nonprofit organization, reported that cardiovascular disease-related deaths reached 931,578, up from 928,741 in 2023. The age-adjusted death rate from cardiovascular diseases also saw a slight increase to 233.3 per 100,000, marking a 4% rise from the previous year's rate of 224.4 per 100,000. This growing prevalence of vascular heart diseases is driving the demand for cardiovascular catheters.
Key players in the cardiovascular catheters market are focusing on developing advanced technologies, such as TRUEref technology, to improve the accuracy and reliability of cardiac mapping. TRUEref technology enhances cardiovascular catheters by providing precise reference signals during cardiac mapping, which improves arrhythmia detection and enables more targeted treatments. For example, in July 2023, Biosense Webster Inc., a US-based company and part of Johnson & Johnson MedTech, introduced the OPTRELL mapping catheter featuring TRUEref technology. This high-density diagnostic catheter, powered by the CARTO 3 System, provides high-definition electrophysiological mapping with 48 small electrodes, allowing clinicians to map complex cardiac arrhythmias with greater precision and develop more effective ablation strategies.
In April 2023, Abbott, a US-based medical device company, acquired Cardiovascular Systems Inc. for $890 million. This acquisition is intended to enhance Abbott's portfolio of vascular devices with Cardiovascular Systems' advanced atherectomy system, thus improving treatment options for peripheral and coronary artery diseases. The acquisition will enable Abbott to offer more comprehensive care for patients with complex arterial conditions. Cardiovascular Systems Inc., based in the US, specializes in developing and commercializing catheters and other devices for treating peripheral and coronary artery diseases.
Major companies operating in the cardiovascular catheters market are Abbott Laboratories, Medtronic plc, Johnson & Johnson MedTech, Koninklijke Philips N.V., Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., ZOLL Medical Corporation, Nipro Corporation, Cook Group Incorporated, Biotronik SE & Co. KG, Merit Medical Systems Inc., LivaNova plc, Cordis Corporation, Asahi Intecc Co. Ltd., AngioDynamics Inc., Endologix Inc., Wellinq, Cardionovum GmbH, Avinger Inc., CathRx, Andocor NV.
Asia-Pacific was the largest region in the cardiovascular catheters market in 2023. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiovascular catheters market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cardiovascular catheters market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Cardiovascular catheters are flexible, slender tubes inserted into blood vessels for diagnostic or therapeutic procedures within the heart and vascular system. They are crucial for delivering treatments, monitoring blood flow, and evaluating heart conditions, and they play a vital role in minimally invasive procedures, enabling access to the heart and blood vessels without the need for open surgery.
The cardiovascular catheters market primarily includes two types of products, cardiovascular therapeutic catheters and cardiovascular diagnostic catheters. Cardiovascular therapeutic catheters are designed for minimally invasive procedures aimed at treating heart and blood vessel conditions, such as clearing blocked arteries or correcting abnormal heart rhythms. These catheters are used in various applications, including coronary artery disease (CAD), cardiac arrhythmia, and heart failure, and are utilized by hospitals, clinics, and ambulatory surgical centers.
The cardiovascular catheters market research report is one of a series of new reports that provides cardiovascular catheters market statistics, including the cardiovascular catheters industry global market size, regional shares, competitors with cardiovascular catheters market share, detailed cardiovascular catheters market segments, market trends, and opportunities, and any further data you may need to thrive in the cardiovascular catheters industry. These cardiovascular catheters market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The cardiovascular catheters market consists of sales of balloon catheters and electrophysiology catheters. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The cardiovascular catheters market size has grown strongly in recent years. It will grow from $20.05 billion in 2024 to $21.87 billion in 2025 at a compound annual growth rate (CAGR) of 9%. The growth in the historic period can be attributed to increase funding for research and development, growth in use of catheters in EP procedures, expansion of cardiac catheterization labs in hospitals, rise in interventional cardiology procedures, and growth in prevalence of diabetes.
The cardiovascular catheters market size is expected to see strong growth in the next few years. It will grow to $30.61 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to focus on reducing healthcare costs, adoption of hybrid operating rooms, rise in investment by both public and private entities in cardiovascular research, increasing use of drug-eluting catheters, and development and adoption of biodegradable catheter materials. Major trends in the forecast period include integration of AI in catheter-based procedures, advanced imaging technologies, development of miniaturized catheters, adoption of robotic-assisted catheter procedures, and development of wireless, battery-free catheters.
The rising prevalence of vascular heart diseases is expected to drive the growth of the cardiovascular catheter market in the future. Vascular heart diseases include various conditions affecting the blood vessels that supply the heart or within the heart itself. Contributing factors such as poor lifestyle habits, aging populations, and increasing rates of diabetes and hypertension are leading to more cases of these diseases. Cardiovascular catheters are essential for patients with vascular heart conditions as they enable minimally invasive procedures to diagnose, treat, and manage issues such as blocked arteries and irregular heart rhythms, resulting in quicker recovery and better outcomes. For instance, in January 2024, the American Heart Association, a US-based nonprofit organization, reported that cardiovascular disease-related deaths reached 931,578, up from 928,741 in 2023. The age-adjusted death rate from cardiovascular diseases also saw a slight increase to 233.3 per 100,000, marking a 4% rise from the previous year's rate of 224.4 per 100,000. This growing prevalence of vascular heart diseases is driving the demand for cardiovascular catheters.
Key players in the cardiovascular catheters market are focusing on developing advanced technologies, such as TRUEref technology, to improve the accuracy and reliability of cardiac mapping. TRUEref technology enhances cardiovascular catheters by providing precise reference signals during cardiac mapping, which improves arrhythmia detection and enables more targeted treatments. For example, in July 2023, Biosense Webster Inc., a US-based company and part of Johnson & Johnson MedTech, introduced the OPTRELL mapping catheter featuring TRUEref technology. This high-density diagnostic catheter, powered by the CARTO 3 System, provides high-definition electrophysiological mapping with 48 small electrodes, allowing clinicians to map complex cardiac arrhythmias with greater precision and develop more effective ablation strategies.
In April 2023, Abbott, a US-based medical device company, acquired Cardiovascular Systems Inc. for $890 million. This acquisition is intended to enhance Abbott's portfolio of vascular devices with Cardiovascular Systems' advanced atherectomy system, thus improving treatment options for peripheral and coronary artery diseases. The acquisition will enable Abbott to offer more comprehensive care for patients with complex arterial conditions. Cardiovascular Systems Inc., based in the US, specializes in developing and commercializing catheters and other devices for treating peripheral and coronary artery diseases.
Major companies operating in the cardiovascular catheters market are Abbott Laboratories, Medtronic plc, Johnson & Johnson MedTech, Koninklijke Philips N.V., Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., ZOLL Medical Corporation, Nipro Corporation, Cook Group Incorporated, Biotronik SE & Co. KG, Merit Medical Systems Inc., LivaNova plc, Cordis Corporation, Asahi Intecc Co. Ltd., AngioDynamics Inc., Endologix Inc., Wellinq, Cardionovum GmbH, Avinger Inc., CathRx, Andocor NV.
Asia-Pacific was the largest region in the cardiovascular catheters market in 2023. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiovascular catheters market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cardiovascular catheters market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Cardiovascular catheters are flexible, slender tubes inserted into blood vessels for diagnostic or therapeutic procedures within the heart and vascular system. They are crucial for delivering treatments, monitoring blood flow, and evaluating heart conditions, and they play a vital role in minimally invasive procedures, enabling access to the heart and blood vessels without the need for open surgery.
The cardiovascular catheters market primarily includes two types of products, cardiovascular therapeutic catheters and cardiovascular diagnostic catheters. Cardiovascular therapeutic catheters are designed for minimally invasive procedures aimed at treating heart and blood vessel conditions, such as clearing blocked arteries or correcting abnormal heart rhythms. These catheters are used in various applications, including coronary artery disease (CAD), cardiac arrhythmia, and heart failure, and are utilized by hospitals, clinics, and ambulatory surgical centers.
The cardiovascular catheters market research report is one of a series of new reports that provides cardiovascular catheters market statistics, including the cardiovascular catheters industry global market size, regional shares, competitors with cardiovascular catheters market share, detailed cardiovascular catheters market segments, market trends, and opportunities, and any further data you may need to thrive in the cardiovascular catheters industry. These cardiovascular catheters market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The cardiovascular catheters market consists of sales of balloon catheters and electrophysiology catheters. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Cardiovascular Catheters Market Characteristics3. Cardiovascular Catheters Market Trends and Strategies4. Cardiovascular Catheters Market - Macro Economic Scenario Including the Impact of Interest Rates, Inflation, Geopolitics, and the Recovery from COVID-19 on the Market32. Global Cardiovascular Catheters Market Competitive Benchmarking and Dashboard33. Key Mergers and Acquisitions in the Cardiovascular Catheters Market34. Recent Developments in the Cardiovascular Catheters Market
5. Global Cardiovascular Catheters Growth Analysis and Strategic Analysis Framework
6. Cardiovascular Catheters Market Segmentation
7. Cardiovascular Catheters Market Regional and Country Analysis
8. Asia-Pacific Cardiovascular Catheters Market
9. China Cardiovascular Catheters Market
10. India Cardiovascular Catheters Market
11. Japan Cardiovascular Catheters Market
12. Australia Cardiovascular Catheters Market
13. Indonesia Cardiovascular Catheters Market
14. South Korea Cardiovascular Catheters Market
15. Western Europe Cardiovascular Catheters Market
16. UK Cardiovascular Catheters Market
17. Germany Cardiovascular Catheters Market
18. France Cardiovascular Catheters Market
19. Italy Cardiovascular Catheters Market
20. Spain Cardiovascular Catheters Market
21. Eastern Europe Cardiovascular Catheters Market
22. Russia Cardiovascular Catheters Market
23. North America Cardiovascular Catheters Market
24. USA Cardiovascular Catheters Market
25. Canada Cardiovascular Catheters Market
26. South America Cardiovascular Catheters Market
27. Brazil Cardiovascular Catheters Market
28. Middle East Cardiovascular Catheters Market
29. Africa Cardiovascular Catheters Market
30. Cardiovascular Catheters Market Competitive Landscape and Company Profiles
31. Cardiovascular Catheters Market Other Major and Innovative Companies
35. Cardiovascular Catheters Market High Potential Countries, Segments and Strategies
36. Appendix
Executive Summary
Cardiovascular Catheters Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on cardiovascular catheters market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for cardiovascular catheters ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cardiovascular catheters market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include: the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Product: Cardiovascular Therapeutic Catheters; Cardiovascular Diagnostic Catheters2) By Application: Coronary Artery Diseases (CAD); Cardiac Arrhythmia; Heart Failure; Other Applications
3) By End User: Hospitals; Clinics; Ambulatory Surgical Centers
Subsegments:
1) By Cardiovascular Therapeutic Catheters: Angioplasty Balloons; Stent Delivery Catheters; Catheters for Ablation Therapy; Intracardiac Catheters; Thrombectomy Catheters2) By Cardiovascular Diagnostic Catheters: Coronary Angiography Catheters; Pressure Monitoring Catheters; Electrophysiology Catheters; Intravenous Catheters for Diagnostic Imaging
Key Companies Mentioned: Abbott Laboratories; Medtronic plc; Johnson & Johnson MedTech; Koninklijke Philips N.V.; Stryker Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
The major companies featured in this Cardiovascular Catheters market report include:- Abbott Laboratories
- Medtronic plc
- Johnson & Johnson MedTech
- Koninklijke Philips N.V.
- Stryker Corporation
- Boston Scientific Corporation
- B. Braun Melsungen AG
- Terumo Corporation
- Edwards Lifesciences Corporation
- W. L. Gore & Associates Inc.
- ZOLL Medical Corporation
- Nipro Corporation
- Cook Group Incorporated
- Biotronik SE & Co. KG
- Merit Medical Systems Inc.
- LivaNova plc
- Cordis Corporation
- Asahi Intecc Co. Ltd.
- AngioDynamics Inc.
- Endologix Inc.
- Wellinq
- Cardionovum GmbH
- Avinger Inc.
- CathRx
- Andocor NV
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 200 |
Published | April 2025 |
Forecast Period | 2025 - 2029 |
Estimated Market Value ( USD | $ 21.87 Billion |
Forecasted Market Value ( USD | $ 30.61 Billion |
Compound Annual Growth Rate | 8.8% |
Regions Covered | Global |
No. of Companies Mentioned | 26 |